September 10, 2025Open Access

Figure S5 from PPARδ Orchestrates a Prometastatic Metabolic Response to Microenvironmental Cues in Pancreatic Cancer

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Bulk transcriptomics reveals that etomoxir and MCM induce EMT in pancreatic cancer, suggesting metabolic influence on tumor progression.

EMT induction occurs following treatment with etomoxir and MCM, enhancing the metastatic potential.
Bulk transcriptomics highlights the role of metabolic changes in promoting tumor metastasis in pancreatic cancer.
Research showcases PPARδ's orchestrating effects on promoting a metabolic response linked to cancer progression.
Findings may guide therapeutic strategies targeting metabolic pathways in pancreatic cancer management.

Parejo-Alonso et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark